ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Preclinical Dose-Escalation Study of ZSJ-0228, a Polymeric Dexamethasone Prodrug, in the Treatment of Murine Lupus Nephritis
Molecular Pharmaceutics
◽
10.1021/acs.molpharmaceut.1c00567
◽
2021
◽
Author(s):
Zhifeng Zhao
◽
Xiaoke Xu
◽
Haochen Jiang
◽
Kirk W. Foster
◽
Zhenshan Jia
◽
...
Keyword(s):
Lupus Nephritis
◽
Dose Escalation
◽
Murine Lupus
◽
Dose Escalation Study
Download Full-text
Related Documents
Cited By
References
Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study
Arthritis Research & Therapy
◽
10.1186/ar3268
◽
2011
◽
Vol 13
(2)
◽
Cited By ~ 8
Author(s):
Hanns-Martin Lorenz
◽
Wilhelm H Schmitt
◽
Vladimir Tesar
◽
Ulf Müller-Ladner
◽
Ingo Tarner
◽
...
Keyword(s):
Lupus Nephritis
◽
Dose Escalation
◽
The Novel
◽
Open Label
◽
Dose Escalation Study
◽
Active Lupus Nephritis
◽
Label Dose
◽
Active Lupus
Download Full-text
Use of Two Technologies, Singulex Single Molecule Counting (SMC)TMand Meso Scale Discovery&[reg](MSD) Technology for Drug Levels Determination of an Antibody Therapeutic, MK-A, in Human Serum in a Dose Escalation Study
10.26226/morressier.57d6b2bbd462b8028d88cc5b
◽
2016
◽
Author(s):
Phyllis Conliffe
Keyword(s):
Human Serum
◽
Single Molecule
◽
Dose Escalation
◽
Meso Scale Discovery
◽
Dose Escalation Study
◽
Drug Levels
◽
Meso Scale
Download Full-text
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Case Medical Research
◽
10.31525/ct1-nct03998345
◽
2019
◽
Author(s):
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
Dose-escalation Study of Oral Administration of LP-108 in Patients With Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
Case Medical Research
◽
10.31525/ct1-nct04139434
◽
2019
◽
Author(s):
Keyword(s):
Acute Myeloid Leukemia
◽
Oral Administration
◽
Dose Escalation
◽
Myelodysplastic Syndromes
◽
Myeloid Leukemia
◽
Chronic Myelomonocytic Leukemia
◽
Dose Escalation Study
◽
Myelomonocytic Leukemia
◽
Acute Myeloid
Download Full-text
Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13409136.14780164
◽
2011
◽
Author(s):
John Laffey
◽
Mairead Hayes
Keyword(s):
Myocardial Infarction
◽
Acute Myocardial Infarction
◽
Stem Cells
◽
Mesenchymal Stem Cells
◽
Dose Escalation
◽
Human Mesenchymal Stem Cells
◽
Dose Escalation Study
◽
Double Blind
◽
Double Blind Placebo
◽
Adult Human
Download Full-text
Faculty Opinions recommendation of The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.6706956.8652054
◽
2011
◽
Author(s):
Tak Mao Chan
◽
Susan Yung
Keyword(s):
Lupus Nephritis
◽
B Cell
◽
Murine Lupus
Download Full-text
Faculty Opinions recommendation of The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.6706956.7829056
◽
2011
◽
Author(s):
Chandra Mohan
◽
Jack Hutcheson
Keyword(s):
Lupus Nephritis
◽
B Cell
◽
Murine Lupus
Download Full-text
Faculty Opinions recommendation of The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.6706956.7599057
◽
2010
◽
Author(s):
Sarah Gaffen
◽
Jill Kramer
Keyword(s):
Lupus Nephritis
◽
B Cell
◽
Murine Lupus
Download Full-text
Faculty Opinions recommendation of Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717955175.793461372
◽
2012
◽
Author(s):
Philip Rosenthal
Keyword(s):
Liver Metastases
◽
Dose Escalation
◽
Phase 1
◽
Dose Escalation Study
Download Full-text
Faculty Opinions recommendation of MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726310584.793533030
◽
2017
◽
Author(s):
Tak Mao Chan
◽
Susan Yung
Keyword(s):
Lupus Nephritis
◽
Mesangial Cells
◽
Type I Interferon
◽
Type I
◽
Murine Lupus
◽
Interferon Pathway
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close